Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 24,684 shares at $7.06 ($174K) on 2024-07-05, disclosed to the SEC on 2024-07-09.
Open-market sale of $174k ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.06 | 12,342 | $87K | 50.0% |
| 2 | $7.06 | 12,342 | $87K | 50.0% |
| Total | $7.06 avg | 24,684 | $174K | 100% |
| Filing → |
| ELYM | SELL | 2024-07-17 | $357K | — | Filing → |
| ELYM | SELL | 2024-07-16 | $948K | — | Filing → |
| ELYM | SELL | 2024-07-11 | $737K | — | Filing → |